Previous COVID-19 vaccines have induced robust IgG and IgA levels against SARS-CoV-2 antigens, dominated by IgG1 and IgG3 responses, responsible for FcγR-mediated effector functions33–35. This evidence concerns the gene IGHG3 and COVID-19.